Early predictors of acute kidney injury after Cardiac Surgery

Background: Acute kidney injury (AKI) represents a significant postoperative complication affecting approximately 50% of cardiac surgery patients, with early detection and intervention being crucial for improved outcomes. Methods: We evaluated early biomarkers of cardiac surgery-associated AKI (CSA-AKI) in 60 patients undergoing elective cardiac procedures requiring extracorporeal circulation, including coronary artery bypass grafting and/or valve replacement surgery. Exclusion criteria encompassed preoperative sepsis, existing renal replacement therapy, advanced age (>80 years), emergency surgical intervention, established chronic renal or hepatic dysfunction, and malignancy. The investigation protocol included sequential measurement of serum neutrophil gelatinase-associated lipocalin (NGAL), neutrophil-lymphocyte ratio (NLR), blood urea nitrogen (BUN), and creatinine at preoperative baseline and at 6th and 24th hours postoperatively. Serum creatinine and BUN were reassessed at 48 hours after surgery. All serum specimens were preserved at −20 ◦C pending laboratory analysis of NGAL and standard hematological parameters. Results: Upon application of Kidney Disease: Improving Global Outcomes (KDIGO) criteria, twenty participants (33.3%) developed CSA-AKI. Comparative analysis revealed significant elevations in both NLR and NGAL at 6th and 24th hours postoperatively relative to preoperative baseline values (p < 0.05) in both AKI and non-AKI cohorts. However, the temporal progression pattern of these biomarkers demonstrated parallel trajectories across both groups (p > 0.05). Conclusions: Our findings suggest that systematic evaluation of serum NGAL and NLR concentrations at preoperative baseline and at 6 and 24 hours following cardiac surgery may facilitate expeditious identification of patients developing AKI, potentially enabling earlier therapeutic intervention.

Acute kidney injury; Cardiac surgery; Neutrophil gelatinase-associated lipocalin; Neutrophil-lymphocyte ratio; Creatinine; Urea

[1] Al-Githmi IS, Abdulqader AA, Alotaibi A, Aldughather BA, Alsulami OA, Wali SM, et al. Acute kidney injury after open heart surgery. Cureus. 2022; 14: e25899.

[2] Mathis MR, Mentz GB, Cao J, Balczewski EA, Janda AM, Likosky DS, et al. Hospital and clinician practice variation in cardiac surgery and postoperative acute kidney injury. JAMA Network. 2025; 8: e258342.

[3] Cheruku SR, Raphael J, Neyra JA, Fox AA. Acute kidney injury after cardiac surgery: prediction, prevention, and management. Anesthesiology. 2023; 139: 880–898.

[4] Jufar AH, Lankadeva YR, May CN, Cochrane AD, Marino B, Bellomo R, et al. Renal and cerebral hypoxia and inflammation during cardiopulmonary bypass. Comprehensive Physiology. 2021; 12: 2799–2834.

[5] Gao X, Wu Y. Perioperative acute kidney injury: the renoprotective effect and mechanism of dexmedetomidine. Biochemical and Biophysical Research Communications. 2024; 695: 149402.

[6] Wang Y, Zhang M, Bi R, Su Y, Quan F, Lin Y, et al. ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury. Redox Biology. 2022; 51: 102262.

[7] Zheng D, Liu J, Piao H, Zhu Z, Wei R, Liu K. ROS-triggered endothelial cell death mechanisms: focus on pyroptosis, parthanatos, and ferroptosis. Frontiers in Immunology. 2022; 13: 1039241.

[8] Liu AB, Tan B, Yang P, Tian N, Li JK, Wang SC, et al. The role of inflammatory response and metabolic reprogramming in sepsis-associated acute kidney injury: mechanistic insights and therapeutic potential. Frontiers in Immunology. 2024; 15: 1487576.

[9] Gosav EM, Tanase DM, Buliga-Finis ON, Rezuș II, Morariu PC, Floria M, et al. The prognostic role of the neutrophil-to-lymphocytes ratio in the most frequent cardiovascular diseases: an update. Life. 2024; 14: 985.

[10] Delanaye P, Cavalier E, Pottel H. Serum creatinine: not so simple! Nephron. 2017; 136: 302–308.

[11] Karkouti K, Rao V, Chan CT, Wijeysundera DN; TACS Investigators. Early rise in postoperative creatinine for identification of acute kidney injury after cardiac surgery. Canadian Journal of Anaesthesia. 2017; 64: 801–809.

[12] Mori K, Nakao K. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney International. 2007; 71: 967–970.

[13] Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A; NGAL Meta-analysis Investigator Group. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. American Journal of Kidney Diseases. 2009; 54: 1012–1024.

[14] Ostermann M, Bellomo R, Burdmann EA, Doi K, Endre ZH, Goldstein SL, et al. Controversies in acute kidney injury: conclusions from a Kidney Disease: improving Global Outcomes (KDIGO) conference. Kidney International. 2020; 98: 294–309.

[15] Zahorec R. Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratislava Medical Journal. 2001; 102: 5–14.

[16] Mallbris L, O’Brien KP, Hulthén A, Sandstedt B, Cowland JB, Borregaard N, et al. Neutrophil gelatinase-associated lipocalin is a marker for dysregulated keratinocyte differentiation in human skin. Experimental Dermatology. 2002; 11: 584–591.

[17] Bao G, Barasch J, Clifton M, Strong RK. Catechol, a urinary Ngal binding Siderophore. Planta Medica. 2008; 74: 74.

[18] Ronco C. NGAL: an emerging biomarker of acute kidney injury. The International Journal of Artificial Organs. 2008; 31: 199–200.

[19] Soni SS, Cruz D, Bobek I, Chionh CY, Nalesso F, Lentini P, et al. NGAL: a biomarker of acute kidney injury and other systemic conditions. International Urology and Nephrology. 2010; 42: 141–150.

[20] Othman HMEDM, Hassan AEM, Elsersi MH, Soliman AKMA, Emam DF. Neutrophil gelatinase-associated lipocalin as a biomarker for predicting acute kidney injury after coronary artery bypass grafting. Ain-Shams Journal of Anesthesiology. 2021; 13: 5.

[21] Prabhu A, Sujatha DI, Ninan B, Vijayalakshmi MA. Neutrophil gelatinase associated lipocalin as a biomarker for acute kidney injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Annals of Vascular Surgery. 2010; 24: 525–531.

[22] Liu Z, Perry LA, Penny‐Dimri JC, Raveendran D, Hu ML, Arslan J, et al. The association of neutrophil‐lymphocyte ratio and platelet‐lymphocyte ratio with retinal vein occlusion: a systematic review and meta-analysis. Acta Ophthalmologica. 2022; 100: 635–647.

[23] Jackson SM, Perry LA, Borg C, Ramson DM, Campbell R, Liu Z, et al. Prognostic significance of preoperative neutrophil-lymphocyte ratio in vascular surgery: systematic review and meta-analysis. Vascular and Endovascular Surgery. 2020; 54: 697–706.

[24] Hu P, Liang H, Zhao Z, Chu H, Mo Z, Song L, et al. High neutrophil-to-lymphocyte ratio as a cost-effective marker of acute kidney injury and in-hospital mortality after cardiac surgery: a case-control study. Renal Failure. 2024; 46: 2417744.

[25] Parlar H, Şaşkın H. Are pre and postoperative platelet to lymphocyte ratio and neutrophil to lymphocyte ratio associated with early postoperative AKI following CABG? Brazilian Journal of Cardiovascular Surgery. 2018; 33: 233–241.

[26] Jiang W, Fang Y, Ding X, Luo Z, Zhang D, Xu X, et al. Association between inflammatory biomarkers and postoperative acute kidney injury after cardiac surgery in patients with preoperative renal dysfunction: a retrospective pilot analysis. Journal of Cardiothoracic Surgery. 2024; 19: 583.

[27] Wheatley J, Liu Z, Loth J, Plummer MP, Penny-Dimri JC, Segal R, et al. The prognostic value of elevated neutrophil-lymphocyte ratio for cardiac surgery-associated acute kidney injury: a systematic review and meta-analysis. Acta Anaesthesiologica Scandinavica. 2023; 67: 131–141.

[28] Sharrod-Cole H, Fenn J, Gama R, Ford C, Giri R, Luckraz H. Utility of plasma NGAL for the diagnosis of AKI following cardiac surgery requiring cardiopulmonary bypass: a systematic review and meta-analysis. Scientific Reports. 2022; 12: 6436.

[29] Reddy RK, Menon S, Selewski DT. Putting the injury back into AKI: understanding AKI phenotypes and improving risk assessment in cardiac surgery-associated AKI. Pediatric Nephrology. 2025; 40: 887–890.

[30] Adisurya G, Abbas KA, Rehatta NM, Hardiono. Plasma neutrophil gelatinase-associated lipocalin and interleukin-9 as acute kidney injury predictors after coronary artery bypass graft following cardiopulmonary bypass. International Journal of Scientific Advances. 2021; 2: 591–596.

[31] Govender P, Tosh W, Burt C, Falter F. Evaluation of increase in intraoperative lactate level as a predictor of outcome in adults after cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia. 2020; 34: 877–884.